维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="BOUMPAS D T"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Commonly used disease-modifying antirheumatic drugs in the treatment of inflammatory arthritis:an update on mechanisms of action 显示文摘	Danning C L Boumpas D T	1998	Clin Exp Rheumatol1998，16，5：	1
2	Increased apoptosis of bone marrow CD34+cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus 显示文摘	PAPADAKI H A BOUMPAS D T GIBSON F M	2001	Br J Haematol2001，115，1：	1
3	Does rituximab increase the incidence of infectious complications?A narrative review显示文摘	Kelesidis T Daikos G Boumpas D	2011	Int J Infect Dis2011，15，1：	1
4	Patho- genesis and treatment of CNS lupus显示文摘	FANOURIAKIS A BOUMPAS D T BERTSIAS G K	2013	Curr Opin Rheuma- tol2013，25，5：	1
5	Toll like receptors and autoimmunity: a critical appraisal 显示文摘	Papadimitraki E D Bertsias G K Boumpas D T	2007	J Autoimmun2007，29，4：	1
6	Does rituximab increase the incidence of infectious complications? A narrative review显示文摘	Kelesidis T Daikos G Boumpas D		0，，：	1
7	Increased apoptosis of bone marrow CD34+ cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus 显示文摘	Papadaki H A Boumpas D T Gobson F M	2001	Br J Haematol2001，115，：	1
8	A short course of BG9588 ( Anti-CD40 Ligand Antibody ) improves serologic activity and decreases hematurla in patients with proliferative lupus glomerulonephfitis 显示文摘	BOUMPAS D T FURIE R MANZI S	2003	Arthritis Rheum2003，48，3：	1
9	Risk for heart pathological changes in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy 显示文摘	Boumpas D T Austin H A 3rd Vaughan E M	1993	Ann Intern Med1993，119，5：	1
10	Cyclophosphamide for the Treatment of Systemic Lupus Erythematosus显示文摘	Takada K Illei G G Boumpas D T	2001	Lupus2001，10，3：	1
11	High-risk features of lupus nephritis:importance of race and clinical and histologic factors in 166 patients显示文摘	AUSTIN H A BOUMPAS D T VAUGHAN E M	1995	Nephrol Dial Transplant1995，10，9：	1
12	Urine proteomics for the early diagnosis of acute glomerulonephritis: Has the time come? 显示文摘	Boumpas D T Kuroiwa T	2007	Arthritis Rheum2007，56，：	1
13	A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy显示文摘	Boumpas D T Tassiulas I O Fleisher T A	1999	Clin Nephrol1999，52，2：	1
14	Therapeutic opportunities in systemic lupus erythematosus:state of the art and prospects for the new deca显示文摘	Bertsias G K Salmon J E Boumpas D T	2010	Ann Rheum Dis2010，69，9：	1
15	Management of Lupus Nap - hritls 显示文摘	Balow J E Boumpas D T Fessler BJ	1996	Kidney Znternoflonal1996，49，2：	1
16	high-risk features of lupus nephritis:importance of race and clinical and histologic factors in 166 patients 显示文摘	Austin H A Boumpas D T Vaughan E M	1995	Nephrol Dial Transplant1995，10，9：	1
17	Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus显示文摘	Papadaki H A Boumpas D T Gibson F M	2001	Br J Haematol2001，115，：	1
18	Biological therapies of autoimmune diseases 显示文摘	Kourbeti I S Boumpas D T	2005	Curt Drug Targets Inflamm Allergy2005，4，1：	1
19	New prospects for treatment of lupus nephritis显示文摘	Balow T E Boumpas D T Austin H A	2000	Semin Nephrol2000，20，1：	1
20	A short course of BG9588(antiCD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis 显示文摘	Furie R Manzi S A	2003	Arthritis Rheum2003，48，3：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示